These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1663 related items for PubMed ID: 28530702

  • 1. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
    Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernàndez-Real JM, Bäckhed F.
    Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
    [Abstract] [Full Text] [Related]

  • 2. Combined effects of Scutellaria baicalensis with metformin on glucose tolerance of patients with type 2 diabetes via gut microbiota modulation.
    Shin NR, Gu N, Choi HS, Kim H.
    Am J Physiol Endocrinol Metab; 2020 Jan 01; 318(1):E52-E61. PubMed ID: 31770016
    [Abstract] [Full Text] [Related]

  • 3. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB, Chae SU, Jo SJ, Jerng UM, Bae SK.
    Int J Mol Sci; 2021 Mar 30; 22(7):. PubMed ID: 33808194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interplay between gut microbiota and tryptophan metabolism in type 2 diabetic mice treated with metformin.
    Xie Y, Li X, Meng Q, Li J, Wang X, Zhu L, Wang W, Li X.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0029124. PubMed ID: 39162538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Gut Microbiome, Metformin, and Aging.
    Induri SNR, Kansara P, Thomas SC, Xu F, Saxena D, Li X.
    Annu Rev Pharmacol Toxicol; 2022 Jan 06; 62():85-108. PubMed ID: 34449247
    [Abstract] [Full Text] [Related]

  • 12. Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients.
    Niu X, Wang Y, Huang L, Guo P, Zhang S, Sun Y, Jin M.
    Front Endocrinol (Lausanne); 2024 Jan 06; 15():1397034. PubMed ID: 39257903
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.
    Chen Y, Shen X, Ma T, Yu X, Kwok LY, Li Y, Sun Z, Li D, Zhang H.
    mSystems; 2023 Feb 23; 8(1):e0130022. PubMed ID: 36688679
    [Abstract] [Full Text] [Related]

  • 14. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
    Cao TTB, Wu KC, Hsu JL, Chang CS, Chou C, Lin CY, Liao YM, Lin PC, Yang LY, Lin HW.
    Front Endocrinol (Lausanne); 2020 Feb 23; 11():573891. PubMed ID: 33071980
    [Abstract] [Full Text] [Related]

  • 15. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
    Bryrup T, Thomsen CW, Kern T, Allin KH, Brandslund I, Jørgensen NR, Vestergaard H, Hansen T, Hansen TH, Pedersen O, Nielsen T.
    Diabetologia; 2019 Jun 23; 62(6):1024-1035. PubMed ID: 30904939
    [Abstract] [Full Text] [Related]

  • 16. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y, Yan L, Chen H, Wu N, Wang W, Wang D.
    Phytomedicine; 2020 Oct 23; 77():153268. PubMed ID: 32663709
    [Abstract] [Full Text] [Related]

  • 17. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
    Pascale A, Marchesi N, Govoni S, Coppola A, Gazzaruso C.
    Curr Opin Pharmacol; 2019 Dec 23; 49():1-5. PubMed ID: 31015106
    [Abstract] [Full Text] [Related]

  • 18. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.
    Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, Liu J, Deng Y, Xia J, Chen B, Zhang S, Yun C, Lian G, Zhang X, Zhang H, Bisson WH, Shi J, Gao X, Ge P, Liu C, Krausz KW, Nichols RG, Cai J, Rimal B, Patterson AD, Wang X, Gonzalez FJ, Jiang C.
    Nat Med; 2018 Dec 23; 24(12):1919-1929. PubMed ID: 30397356
    [Abstract] [Full Text] [Related]

  • 19. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C, Ma S, Wu J, Luo L, Qiao S, Li R, Xu W, Wang N, Zhao B, Wang X, Zhang Y, Wang X.
    Pharmacol Res; 2020 Sep 23; 159():104985. PubMed ID: 32504839
    [Abstract] [Full Text] [Related]

  • 20. Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment.
    Ezzamouri B, Rosario D, Bidkhori G, Lee S, Uhlen M, Shoaie S.
    NPJ Syst Biol Appl; 2023 Jan 21; 9(1):2. PubMed ID: 36681701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.